Genetic Diagnosis in Neonatal Encephalopathy With Hypoxic Brain Damage Using Targeted Gene Panel Sequencing
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background and Purpose Neonatal encephalopathy (NE) is a neurological syndrome that presents with severe neurological impairments and complications. Hypoxic-ischemic encephalopathy is a major contributor to poor outcomes, being responsible for 50%–80% of admissions to neonatal intensive care units. However, some cases of NE accompanied by hypoxic brain damage cannot be solely attributed to hypoxia-ischemia. We aimed to identify diverse pathogenic genetic variations that may be associated with cases of NE accompanied by hypoxic brain damage rather than hypoxia-ischemia. Methods We collected data from 34 patients diagnosed with NE accompanied by hypoxic brain damage over a 10-year period. Patients with the following specific conditions were excluded: 1) premature birth (<32 weeks), 2) no history of hypoxic events, 3) related anomalies, 4) neonatal infections, 5) antenatal or perinatal obstetrical complications, 6) severe hypoxia due to other medical conditions, and 7) early death (within 1 week). A comprehensive review of clinical and radiological features was conducted. Results A genetic diagnosis was made in 11 (32.4%) patients, with pathogenic variants being identified in the following 9 genes: CACNA1A (n=2), KCNQ2 (n=2), SCN2A (n=1), SCN8A (n=1), STXBP1 (n=1), NSD1 (n=1), PURA (n=1), ZBTB20 (n=1), and ENG (n=1). No specific treatment outcomes or clinical features other than preterm birth were associated with the results of the genetic analyses. Personalized treatments based on the results of genetic tests were attempted, such as the administration of sodium-channel blockers in patients with KCNQ2 or SCN8A variants and the implementation of a ketogenic diet in patients with STXBP1 or SCN2A mutations, which demonstrated some degree of effectiveness in these patients. Conclusions Genetic analyses may help in diagnosing the underlying etiology of NE and concurrent hypoxic brain damage, irrespective of the initial clinical features.
Abstract
Background and Purpose Neonatal encephalopathy (NE) is a neurological syndrome that presents with severe neurological impairments and complications. Hypoxic-ischemic encephalopathy is a major contributor to poor outcomes, being responsible for 50%–80% of admissions to neonatal intensive care units. However, some cases of NE accompanied by hypoxic brain damage cannot be solely attributed to hypoxia-ischemia. We aimed to identify diverse pathogenic genetic variations that may be associated with cases of NE accompanied by hypoxic brain damage rather than hypoxia-ischemia. Methods We collected data from 34 patients diagnosed with NE accompanied by hypoxic brain damage over a 10-year period. Patients with the following specific conditions were excluded: 1) premature birth (<32 weeks), 2) no history of hypoxic events, 3) related anomalies, 4) neonatal infections, 5) antenatal or perinatal obstetrical complications, 6) severe hypoxia due to other medical conditions, and 7) early death (within 1 week). A comprehensive review of clinical and radiological features was conducted. Results A genetic diagnosis was made in 11 (32.4%) patients, with pathogenic variants being identified in the following 9 genes: CACNA1A (n=2), KCNQ2 (n=2), SCN2A (n=1), SCN8A (n=1), STXBP1 (n=1), NSD1 (n=1), PURA (n=1), ZBTB20 (n=1), and ENG (n=1). No specific treatment outcomes or clinical features other than preterm birth were associated with the results of the genetic analyses. Personalized treatments based on the results of genetic tests were attempted, such as the administration of sodium-channel blockers in patients with KCNQ2 or SCN8A variants and the implementation of a ketogenic diet in patients with STXBP1 or SCN2A mutations, which demonstrated some degree of effectiveness in these patients. Conclusions Genetic analyses may help in diagnosing the underlying etiology of NE and concurrent hypoxic brain damage, irrespective of the initial clinical features.
참고문헌 (47)
- Leviton A, "Problems with definitions and classifications of newborn encephalopathy", Pediatr Neurol, 8, pp.85~90 (1992)
- Ferriero DM, "Neonatal brain injury", N Engl J Med, 351, pp.1985~1995 (2004)
- Brown JK, "Neurological aspects of perinatal asphyxia", Dev Med Child Neurol, 16, pp.567~580 (1974)
- Levene ML, "The incidence and severity of post-asphyxial encephalopathy in full-term infants", Early Hum Dev, 11, pp.21~26 (1985)
- Volpe JJ, "Neurology of the newborn", pp.25~ (2001), WB Saunders
- Kurinczuk JJ, "Epidemiology of neonatal encephalopathy and hypoxic-ischaemic encephalopathy", Early Hum Dev, 86, pp.329~338 (2010)
- Badawi N, "Intrapartum risk factors for newborn encephalopathy : the Western Australian case-control study", BMJ, 317, pp.1554~1558 (1998)
- Badawi N, "Antepartum risk factors for newborn encephalopathy : the Western Australian case-control study", BMJ, 317, pp.1549~1553 (1998)
- Blume HK, "Intrapartum fever and chorioamnionitis as risks for encephalopathy in term newborns : a casecontrol study", Dev Med Child Neurol, 50, pp.19~24 (2008)
- Nelson KB, "Antecedents of neonatal encephalopathy in the Vermont Oxford network encephalopathy registry", Pediatrics, 130, pp.878~886 (2012)
- Volpe JJ, "Neonatal encephalopathy : an inadequate term for hypoxicischemic encephalopathy", Ann Neurol, 72, pp.156~166 (2012)
- Aslam S, "Neonatal encephalopathy : need for recognition of multiple etiologies for optimal management", Front Pediatr, 7, pp.142~ (2019)
- Sandoval Karamian AG, "Neonatal encephalopathy : etiologies other than hypoxic-ischemic encephalopathy", Semin Fetal Neonatal Med, 26, pp.101272~ (2021)
- Bruun TUJ, "Prospective cohort study for identification of underlying genetic causes in neonatal encephalopathy using whole-exome sequencing", Genet Med, 20, pp.486~494 (2018)
- Yang L, "Clinical features and underlying genetic causes in neonatal encephalopathy : a large cohort study", Clin Genet, 98, pp.365~373 (2020)
- Xiao TT, "Genotype and phenotype analysis of neonates with neonatal encephalopathy complicated with perinatal hypoxic event", Zhonghua Er Ke Za Zhi, 59, pp.280~285 (2021)
- Lenahan A, "Characteristics, genetic testing, and diagnoses of infants with neonatal encephalopathy not due to hypoxic ischemic encephalopathy : a cohort study", J Pediatr, 260, pp.113533~ (2023)
- Woodward KE, "Identifying genetic susceptibility in neonates with hypoxic-ischemic encephalopathy : a retrospective case series", J Child Neurol, 38, pp.16~24 (2023)
- Palisano R, "Development and reliability of a system to classify gross motor function in children with cerebral palsy", Dev Med Child Neurol, 39, pp.214~223 (1997)
- Douglas-Escobar M, "Hypoxic-ischemic encephalopathy : a review for the clinician", JAMA Pediatr, 169, pp.397~403 (2015)
- Trivedi SB, "A validated clinical MRI injury scoring system in neonatal hypoxic-ischemic encephalopathy", Pediatr Radiol, 47, pp.1491~1499 (2017)
- Wisnowski JL, "Neuroimaging in the term newborn with neonatal encephalopathy", Semin Fetal Neonatal Med, 26, pp.101304~ (2021)
- Richards S, "Standards and guidelines for the interpretation of sequence variants : a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology", Genet Med, 17, pp.405~424 (2015)
- Ahearne CE, "Short and long term prognosis in perinatal asphyxia : an update", World J Clin Pediatr, 5, pp.67~74 (2016)
- Alkholy UM, "Early predictors of brain damage in full-term newborns with hypoxic ischemic encephalopathy", Neuropsychiatr Dis Treat, 13, pp.2133~2139 (2017)
- Shim GH, "Which factors predict outcomes of neonates with hypoxicischemic encephalopathy following therapeutic hypothermia?", Clin Exp Pediatr, 64, pp.169~171 (2021)
- Sun H, "Characteristics of respiratory distress syndrome in infants of different gestational ages", Lung, 191, pp.425~433 (2013)
- Debillon T, "Respiratory distress management in moderate and late preterm infants : the NEOBS study", Arch Pediatr, 28, pp.392~397 (2021)
- Smyrni N, "Moderately and late preterm infants : short-and long-term outcomes from a registry-based cohort", Front Neurol, 12, pp.628066~ (2021)
- Allen AS, "De novo mutations in epileptic encephalopathies", Nature, 501, pp.217~221 (2013)
- Ko A, "Targeted gene panel and genotype-phenotype correlation in children with developmental and epileptic encephalopathy", Epilepsy Res, 141, pp.48~55 (2018)
- Lee S, "Genetic diagnosis and clinical characteristics by etiological classification in earlyonset epileptic encephalopathy with burst suppression pattern", Epilepsy Res, 163, pp.106323~ (2020)
- Hayashida T, "CACNA1A-related early-onset encephalopathy with myoclonic epilepsy : a case report", Brain Dev, 40, pp.130~133 (2018)
- Numis AL, "KCNQ2 encephalopathy : delineation of the electroclinical phenotype and treatment response", Neurology, 82, pp.368~370 (2014)
- Howell KB, "SCN2A encephalopathy : a major cause of epilepsy of infancy with migrating focal seizures", Neurology, 85, pp.958~966 (2015)
- Gardella E, "The phenotype of SCN8A developmental and epileptic encephalopathy", Neurology, 91, pp.e1112~e1124 (2018)
- Le Roux M, "CACNA1A-associated epilepsy : electroclinical findings and treatment response on seizures in 18 patients", Eur J Paediatr Neurol, 33, pp.75~85 (2021)
- Thalwitzer KM, "Natural history and developmental trajectories of individuals with disease-causing variants in STXBP1", Neurology, 101, pp.e879~e891 (2023)
- "Sotos Syndrome. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Bean LJH, et al., editors. GeneReviews®" (2022)[URL]
- Singh P, "Neonatal Sotos syndrome : a novel frameshift mutation of the NSD1 gene associated with neonatal encephalopathy presenting without overgrowth", J Pediatr Neurol, 22, pp.56~59 (2024)
- Lu DF, "A case of Sotos syndrome in a preterm infant with severe bronchopulmonary dysplasia and congenital heart disease", Children(Basel), 10, pp.1111~ (2023)
- Alby C, "Novel de novo ZBTB20 mutations in three cases with Primrose syndrome and constant corpus callosum anomalies", Am J Med Genet A, 176, pp.1091~1098 (2018)
- Cleaver R, "Refining the Primrose syndrome phenotype : a study of five patients with ZBTB20 de novo variants and a review of the literature", Am J Med Genet A, 179, pp.344~349 (2019)
- "PURA-Related Neurodevelopmental Disorders. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Bean LJH, et al., editors. GeneReviews®" (2017)[URL]
- Mishra S, "Expanding the phenotype of PURArelated neurodevelopmental disorder : a close differential diagnosis of infantile hypotonia with psychomotor retardation and characteristic facies", Clin Dysmorphol, 30, pp.1~5 (2021)
- Llorens-Bobadilla E, "Single-cell transcriptomics reveals a population of dormant neural stem cells that become activated upon brain injury", Cell Stem Cell, 17, pp.329~340 (2015)
- Zhou HS, "An integrated analysis of hypoxic-ischemic encephalopathy-related cell sequencing outcomes via genes network construction", Ibrain, 8, pp.78~92 (2022)